Elranatamab-Bcmm (Anti-BCMA & CD3)
Product Specifications
CAS Number
2408850-14-4
Synonyms
ElrexfioTM, PF-06863135
SKU
C00876-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Elranatamab-bcmm is a bispecific T-cell engager (BiTE) monoclonal antibody that targets CD3 and B-cell maturation antigen (BCMA), promoting the recruitment and activation of T cells to effectively eliminate malignant myeloma cells. It is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma. MW: 145.44 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items